Fifth EDCTP Forum presentations
Posted by Daniela Pereira-Lengkeek on 30 October 2009 at 16:28
The presentations of all three Forum days and electronic posters are now available for download.
Global picture
Prof. Charles Mgone, EDCTP Executive Director
Introduction of the theme: Fighting HIV/AIDS, malaria and tuberculosis: one world one partnership
Download presentation
Dr Diana Dunstan, EDCTP Assembly Chairperson
European and African programmes partnership: role of European member states and agencies
Download presentation
Dr Placido Cardoso, West African Health Organisation (WAHO)
Health research initiatives in West African Region
Download presentation
Dr Marlyse Peyou Ndi, OCEAC
Health research initiatives in Central African Region
Download presentation
Global developments
Dr Andrew Kitua, WHO/TDR
Networks of Excellence: Overview
Download presentation
Prof. Francine Ntoumi, CANTAM Coordinator
Central Africa Network of Excellence in Clinical Research, CANTAM
Download presentation
Dr Liliana Chocarro, WHO/FCH/IVB/QSS Regulatory Pathways
Harmonisation and strengthening of regulatory activities in sub-Saharan Africa
Download presentation
Prof. Carel IJsselmuiden, Council on Health Research for Development (COHRED)
Ethics strengthening in Africa- to include EDCTPs ethics mapping project and other EDCTP ethics activity
Download presentation
Ms Amber Abrams, South African Cochrane Centre, Cape Town, South Africa
The Pan African Clinical Trials Registry (PACTR): Leading the way in prospective clinical trials registration in Africa
Download presentation
EDCTP and Global Partnerships
Dr Pontiano Kaleebu, MRC-UVRI Uganda Research Unit on AIDS and UVRI-IAVI HIV Vaccine Program, Entebbe, Uganda
The AAVP and UVRI model: Building research capacity through partnerships in synergy with EDCTP
Download presentation
Dr Annaléne Nel, International Partnership for Microbicides, USA
Progress on the Path to HIV Prevention: Building Capacity and Partnerships in Africa
Download presentation
Dr Val Snewin, Wellcome Trust, London, United Kingdom
Health Research Capacity Strengthening
Download presentation
Ms Siobhan Malone, Bill & Melinda Gates Foundation
The Bill & Melinda Gates Foundation’s partnership with EDCTP
Download presentation
Dr Garry Aslanyan, UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (TDR)
ESSENCE: Enhancing Support for Strengthening the Effectiveness of National Capacity Effort
Download presentation
Prof. Wen Kilama, African Malaria Network Trust, Dar es Salaam, Tanzania
Capacity Strengthening and Malaria Vaccine Development
Download presentation
Dr Egeruan Babatunde Imoukhuede, European Malaria Vaccine Initiative
Perspectives for the future
Download presentation
Dr Stephan Duparc, Medicines for Malaria Venture, Geneva, Switzerland
Partnering for success: MMV’s long term view of Clinical Development
Download presentation
Dr Anthony Hawkridge, Aeras Global TB Vaccine Foundation, Cape Town, South Africa
EDCTP and Global Partnerships – Aeras Global TB Vaccine Foundation
Download presentation
Capacity development in sub-Saharan Africa
Dr Michael Makanga, EDCTP Director South-South Cooperation and Head of Africa Office
Challenges of Health Research Capacity Development in SSA: The EDCTP Strategy
Download presentation
Clinical trials in sub-Saharan Africa
HIV/AIDS
Anatoli Kamali, MRC/UVRI Uganda Research Unit on AIDS
Recent advances in HIV/AIDS
Download presentation
Said Aboud, Muhimbili University of Health and Allied Sciences (MUHAS)
Safety and immunogenicity of a multigene multiclade Hiv-1 DNA plasmid vaccine boosted with heterologous HIV mva among healthy volunteers in Dar Es Salaam, Tanzania
Download presentation
Joel Francis, Muhimbili Medical Research Centre
Safety profile of a Multigene, multiclade HIV-1 DNA plasmid vaccine boosted with HIV-1 MVA among healthy volunteers in Dar Es Salaam, Tanzania
Download presentation
Elise Arrivé, Université Victor Segalen Bordeaux, France
Tolerance and viral dynamics after short-course of nevirapine, tenofovir disoproxil fumarate and emtricitabine (TDF/FTC) to delivering women and neonates
Download presentation
Veronica Mulenga, University Teaching Hospital, Lusaka, Zambia
Strategies for Nevirapine initiation in HIV-infected children taking paediatric fixed-dose combination ‘baby pills’ in Zambia: A randomised controlled trial
Download presentation
Mirjam Oudijk, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands
Pharmacokinetics of nevirapine in young children during combined ART and rifampicin-containing antituberculosis treatment
Download presentation
Omar JM Hamza, Muhimbili University of Health and Allied Sciences, Tanzania
Single-dose fluconazole versus standard two weeks therapy for oropharyngeal candidiasis in HIV-infected patients: A randomized, double-blind placebo controlled trial
Download presentation
Julius Atashili, University of Buea, Cameroon
High prevalence of cervical squamous intraepithelial lesions in women on antiretroviral therapy in Cameroon: Is targeted screening feasible?
Download presentation
Bahati Andrew, Mwanza Intervention Trials Unit, NIMR, Mwanza, Tanzania & Justine Bukenya, MRC/UVRI Uganda Research Unit on AIDS, Entebbe, Uganda
Prevalence of intra-vaginal practices in EDCTP cohorts in Uganda and Tanzania & Sexual risk behaviour and risk perception among female sex workers enrolled in a microbicide feasibility study in Kampala, Uganda
Download presentation
Papa Gallo Sow, Institute of Social Hygiene, Dakar, Senegal
Perceptions and practices regarding microbicides. A baseline survey of the social health institute of Dakar
Download presentation
Suzan Nakate, Makerere University, Kampala, Uganda
Barriers to adherence to clinical appointments in a free Urban HIV care facility. A case of the Infectious Diseases Institute Kampala, Uganda
Download presentation
Mariam A Adetunji, Nigeria Institute of Medical Research, Lagos, Nigeria
Risk of coronary heart disease based on ratio of total cholesterol to high density lipoprotein in HIV infected ARV naïve patients
Download presentation
Louis-Marie Yindom, Medical Research Council Laboratories, Fajara, The Gambia
Hla alleles and kir genes frequencies in HIV-2 infected individuals from two cohorts in West Africa
Download presentation
Mattia Prosperi, EuResist Network GEIE, Bologna, Italy
Prediction of antiretroviral therapy outcomes in poor resource countries: Comparison between genotype resistance testing based versus treatment history models
Download presentation
Sabina Mugusi, Muhimbili National Hospital, Dar es Salaam, Tanzania
The effect of rifampicin on clinical outcomes in patients treated with efavirenz containing HAART
Download presentation
Joseph Vyankandondera, Projet Ubuzima, Kigali, Rwanda
Prevalence of HPV and association with other STIs among High-Risk women in Kigali, Rwanda
Download presentation
Summary and recommendations
Download presentation
Malaria
Abdoulaye Djimde, University of Bamako, Mali
Recent advances in malaria
Download presentation
Umberto D’Alessandro, Institute of Tropical Medicine, Antwerp
Artemisinin-based combinations for treating uncomplicated malaria in African children: The 4abc trial, preliminary results
Download presentation
Badara Cisse, University of Dakar, Senegal
A randomized trial of the efficacy and safety of piperaquine in combination with dihydro-artemisinin or sulphadoxine-pyrimethamine for seasonal intermittent preventive treatment (IPT) in Senegalese children
Download presentation
Patrice Piola, Epicentre, Paris, France
Efficacy and safety of quinine versus artemether-lumefantrine in uncomplicated malaria during pregnancy, Mbarara, Uganda
Download presentation
Soren Jepsen, Statens Serum Institut, Copenhagen, Denmark
Malaria vaccine GMZ2 pre-clinical selection and clinical development
Download presentation
Saadou Issifou, MRU ASH Gabon
Phase Ib randomized controlled double blind trial to evaluate the safety & immunogenicity of 30 and 100 µg GMZ2 candidate malaria vaccine in Gabonese children aged 1-5 Years
Download presentation
Sanie Sesay, Medical Research Council (UK), Banjul, The Gambia
Baseline epidemiological study in preparation for a phase IIb proof of concept efficacy study of GMZ2 candidate malaria vaccine in children aged 12 – 84 months old
Download presentation
Sodiomon Sirima, Centre National de Recherche et de Formation sur le Paludisme (CNRFP), Ouagadougou, Burkina Faso
Facing the challenge of building malaria clinical trials site in developing country: Achievements and lessons from the Balonghin Malaria Vaccine Trial Centre in Burkina Faso
Download presentation
Saadou Issifou, MRU ASH Gabon
A phase II randomized, double-blind study to compare the efficacy, safety, tolerability, and pharmacokinetics of two regimens using intravenous artesuate
Download presentation
Davis Nwakanma, Medical Research Council (UK), Banjul, The Gambia
Application of real-time quantitative polymerase chain reaction ‘opcr’ in anti-malarial drug trial
Download presentation
Alexis Nzila, KEMRI-Wellcome Trust Collaborative Research Program, Kilifi, Kenya
In-vitro chemosensitization of antimalarials by verapamil and probenecid in Plasmodium falciparum
Download presentation
Leah Mwai, KEMRI-Wellcome Trust, Kilifi, Kenya
Towards understanding the mechanisms of lumefantrine resistance
Download presentation
Takafira Mduluza, University of Zimbabwe, Harate, Zimbabwe
Cytokine gene polymorphism analysis in children exposed to malaria and/or helminths infections in Zimbabwe
Download presentation
Ayola Akim Adegnika, Medical Research Unit, Albert Schweitzer Hospital, Lambaréné, Gabon
Ascaris lubriciodes as a risk factor for P. falciparum malaria infection during pregnancy in Lambaréné, Gabon
Download presentation
Daniel Dodoo, Noguchi Memorial Institute for Medical Research, University of Ghana, Legon, Ghana
The Afro-immuno assay multi-centre network project and capacity building for malaria vaccine development in Africa
Download presentation
Aïssatou Touré, Institut Pasteur de Dakar, Senegal
The ADRB assay: a new tool, correlated with clinical protection from Plasmodium falciparum malaria, to test malaria vaccine
Download presentation
Charles Arama, Wenner-Gren Institute, Stockholm University, Sweden
Decreased percentage of plasmacytoid dendritic cells and increased plasma levels of interferon alpha in Fulani children undergoing Plasmodium falciparum infection in Mali
Download presentation
Victor Chalwe, Institute of Tropical Medicine, Antwerp, Belgium
HIV-1 infection increases the risk of severe malaria in semi-immune adults in Zambia
Download presentation
Tuberculosis
Willem Hanekom, South African Tuberculosis Vaccine Initiative, University of Cape Town, South Africa
Advances in TB
Download presentation
Andrew Nunn, Medical Research Council Clinical Trials Unit, London, United Kingdom
An international multicentre controlled clinical trial to evaluate high dose rifapentine and a quinolone in the treatment of pulmonary tuberculosis (Rifaquin)
Download presentation
Anthony Hawkridge, Aeras Global TB Vaccine Foundation, Cape Town, South Africa
Partnering to support research capacity in tuberculosis endemic countries
Download presentation
Mugahid Elhassan, College of Medical Laboratory Sciences, Khartoum, Sudan
Similarity between pulmonary tuberculosis and pulmonary nocardiosis; (A bacteriological and proteomic study)
Download presentation
Videlis Nduba, KEMRI/CDC Research and Public Health Collaboration, Kisumu, Kenya
The prevalence of tuberculosis infection and disease among adolescents in western Kenya: preparation for future TB vaccine trials
Download presentation
Peter Nyamthimba Onyango, KEMRI/CDC Research and Public Health Collaboration, Kisumu, Kenya
A mobile field site as a model for enrolment and follow up in a tuberculosis incidence cohort in adolescents, western Kenya, in preparation for future vaccine trials
Download presentation
Charles Mtabho, Kilimanjaro Clinical Research Institute, Moshi, Tanzania
The magnitude of childhood tuberculosis in Kilimanjaro region, northern Tanzania; A retrospective study from regional tuberculosis program registry
Download presentation
Grace Kiringa, Kenya Medical Research Institute, Kisumu, Kenya
A prospective cohort study to evaluate incidence of tuberculosis in infants, western Kenya
Download presentation
Gibson Kibiki, Kilimanjaro Clinical Research Institute, Moshi, Tanzania
New drugs against tuberculosis: Problems, progress, and evaluation of agents in clinical development
Download presentation
Yusuf Mohammed, International Center for AIDS care and treatment program (ICAP), Kaduna, Nigeria
Response to treatment in sputum smear positive pulmonary tuberculosis patients in relation to human immunodeficiency virus in Kano, Nigeria
Download presentation
Sven Friedrich, University of Stellenbosch, Tugerberg, South Africa
Comparison of smear microscopy, solid culture and liquid culture for monitoring treatment response in pulmonary tuberculosis
Download presentation
Bernd Eisele, Vakzine Projekt Management GmbH, Hannover, Germany
Induction of antigen specific multifunctional T cells after vaccination with the live recombinant tuberculosis vaccine VPM1002 in a Phase I clinical trial
Download presentation
Jan Verschoor, University of Pretoria, South Africa
Mycolic acid antibody real-time inhibition test demonstrates that anti-mycolic acid antibodies are surrogate markers for active tuberculosis
Download presentation
Hulda Swai, Council for Industrial Scientific Research (CSIR), Pretoria, South Africa
Novel approach to address the tubercukisus treatment regime
Download presentation
Agatha Ani, University of Jos, Nigeria
Dominant Mycobacterium tuberculosis genotypes in Nigeria
Download presentation
Amos Kahwa, National Institute for Medical Research, Dar es Salaam, Tanzania
Estimates of genetic variability of M. tuberculosis complex and its association with drug resistance and treatment outcomes in Tanzania
Download presentation
Kebba Touray, Medical Research Council (UK), Banjul, The Gambia
Spatial analysis of tuberculosis in an urban West African setting: Is there evidence of clustering?
Download presentation
Electronic posters
HIV/AIDS
Olawale Salami, Clinical Research Unit, Gede Foundation, Abuja, Nigeria
Episodic viremia during suppresive antiretroviral therapy: Impact on treatment outcomes in Nigerian patients
Download presentation
Moses Kamya, Makerere University College of Health Sciences, Kampala, Uganda
Prophylaxis and treatment of malaria in HIV infected populations
Download presentation
Mohammed Lamorde, Makerere University, Kampala, Uganda
Clinical pharmacology for global health – A north – south partnership
Download presentation
Getnet Yimer Ali, Addis Ababa University, Ethiopia
Efavirenz based antiretroviral therapy induced hepatotoxicity among Ethiopian patients
Download presentation
Nicaise Ndembi, MRC/UVRI Uganda Research Unit on AIDS, Entebbe, Uganda
Molecular epidemiology of HIV-1 dual infection in monogamous and polygamous sexual partners in Uganda
Download presentation
Anders Sönnerborg, Karolinska Institutet, Stockholm, Sweden
Infcare HIV – A health-informatic tool for improvement of HIV clinical care and research in Africa
Download presentation
Micah Oyaro, University of Nairobi, Kenya
Hepatitis B and C viral co-infections among HIV-infected treatment naive participants recruited in HIV-1 molecular diversity cross-sectional survey, western Kenya
Download presentation
Gershim Asiki, MRC/UVRI Uganda Research Unit on AIDS and UVRI-IAVI, Uganda
Prevalence and risk factors for HIV and syphilis among fishing populations of Uganda. A capacity development project for HIV prevention research
Download presentation
Francesca Incardona, EuResist Network GEIE, Muhimbili Nat
Expanding the world’s largest HIV drug resistance database, Euresist, into an African context
Download presentation
Mercy Chiduo, National Institute for Medical Research, Tanga Centre, Tanzania
Reducing loss to follow-up in the COMTRU project
Download presentation
Ammiel Gasarabwe, Projet Ubuzima, Kigali, Rwanda
Association between HIV-infection and infertility in Rwanda: A case-control study
Download presentation
Lambert Mwambarangwe, Projet Ubuzima, Kigali, Rwanda
HIV prevalence and risk factors in a community-based sample of female sex workers, Kigali, Rwanda
Download presentation
Mirabeau Tatfeng, College of Health Sciences, Niger Delta University, Nigeria
Anti-inflammatory cytokines and Haematological indices in HIV and HBV seropositive adults with uncomplicated Plasmodium falciparum malaria
Download presentation
Elias Onyoh, Institute of Endemic Diseases (IEND), University of Khartoum, Sudan
Molecular detection of chemokinelLigand 3-like 1 (CCL3L1, MIP-1αp Or LD78β) gene copy number amongst HIV-1 positive patients in Khartoum, Sudan
Download presentation
Gelase Fredy Nsonde Ntandou, Université Marien-NGOUABI, Brazzaville, Congo
Ethnobotanic survey, cytotoxicity, in vitro study and identification of anti-HIV1 active compounds from plants used in Congolese Pharmacopoeia
Download presentation
Daniel Bugembe Lule, MRC/UVRI Uganda Research Unit on AIDS, Entebbe, Uganda
Pattern of interferon gamma T-cell responses to HIV-1 and their association to CD4 counts and viral load trajectory in acute and early HIV-1 infection
Download presentation
Khamis Tomusange, MRC/UVRI Uganda Research Unit on AIDS, Entebbe, Uganda
Prevalence of neutralizing antibody responses in chronic clades A and D human immunodeficiency virus type 1 (HIV-1) infections
Download presentation
Simon Peter Mayanja, St. Francis Hospital, Nsambya – Kampala, Uganda
Domestic violence among HIV/AIDS patients attending Nsambya Hospital HIV chronic care clinic
Download presentation
Edith Tarimo, Muhimbili University of Health and Allied Sciences (MUHAS), Dar es Salaam, Tanzania
Stigma related factors and patients’ compliance on anti-retroviral therapy: Listening to the voices of the health care providers in Tanzania
Download presentation
Asungushe Kayombo, Mwanza Intervention Trials Unit, Mwanza, Tanzania
Factors associated with HIV infection and pregnancy at screening in a feasibility study to prepare for future HIV prevention trials in northwest Tanzania
Download presentation
Melissa Wallace, Desmond Tutu HIV Centre, University of Cape Town, South Africa
Ethical-legal challenges in conducting HIV prevention trial research with adolescents: A South African case study of tool development
Download presentation
Malaria
Sanie Sesay, Medical Research Council, Banjul, The Gambia
A pilot study of Intermittent Preventive Treatment (IPT) and home based management of malaria in a rural area of The Gambia
Download presentation
Catherine Falade, University of Ibadan, Nigeria
Comparative efficacy and safety of Artemether-Lumefantrine, Artesunate plus Amodiaquine and Artesunate plus Amodiaquine plus Chlorpheniramine (Artemoclo)
Download presentation
Harry Tagbor, Kwame Nkrumah University of Science & Technology, Kumasi, Ghana
Intermittent preventive treatment with Sulfadoxine-Pyrimethamine versus intermittent screening and treatment of malaria in pregnancy
Download presentation
Jean-Pierre Van Geertruyden, Institute of Tropical Medicine, Antwerp, Belgium
Risk of haemolysis after Chlorproguanil-Dapsone plus Artesunate treatment in G6PD deficient infants
Download presentation
Ramadhani Noor, African Malaria Network Trust, Dar es Salaam, Tanzania
Malaria vaccines for Africa – Experience of AMANET R&D
Download presentation
Fred Kironde, Makerere University, Uganda
Baseline information at Iganga-Mayuge demographic surveillance site: A new malaria field study site in eastern Uganda
Download presentation
Yaw Afrane, Centre for Global Health Research, Kenya Medical Research Institute, Kisumu, Kenya
Spatial distribution and temporal dynamics of clinical malaria cases in a western Kenya highland site
Download presentation
Edith Christiane Bougouma, Centre National de Recherche et de Formation sur le Paludisme, Ouagadougou, Burkina Faso
Haemoglobine S and C protect children under five 5 years living in the Saponé Health District (Burkina Faso) against the malaria infection
Download presentation
Eboumbou Moukoko Else Carole, University of Buea, Cameroon
Genetic identification of Plasmodium falciparum parasite virulence markers according to local populations
Download presentation
Issa Nébié, Polytech University of Bobo, Burkina Faso
Regulatory T-cells in sympatric ethnic groups with different susceptibility to malaria in Burkina Faso
Download presentation
Charles Mwanziva, Tumaini University, Kilimanjaro Christian Medical College, Tanzania
Overuse of artemisinin-combination therapy in Mto Wa Mbu (river of mosquitoes), an area misinterpreted as high endemic for malaria
Download presentation
Nancy Nyakoe, Walter Reed Project, Kenya Medical Research Institute, Kisumu, Kenya
Complement utilization in children with severe malarial anemia
Download presentation
Ramatoulie Janha, Medical Research Council, Banjul, The Gambia
Variation in cytochrome P450 CYP2C19/CYP2C9 and efficacy of Chlorproguanil and Dapsone
Download presentation
Erasto V Mbugi, Wageningen University, Wageningen, the Netherlands
Effect of nutrient deficiencies on in vitro cytokine response of peripheral blood mononuclear cells to Plasmodium falciparuminfection
Download presentation
Adama Gansané, CNRFP, Ouagadougou, Burkina Faso
Hematological parameters changes in children less than 6 years living in malaria endemic area: Implication for future malaria vaccine trials
Download presentation
Amidou Diarra, CNRFP, Ouagadougou, Burkina Faso
Antibodies to malaria vaccine candidates and Chloroquine Or Sulfadoxine/Pyrimethamine treatment efficacy in an andemic area of Burkina Faso
Download presentation
Alphonse Ouedraogo, CNRFP, Ouagadougou, Burkina Faso
Malaria morbidity in a high and seasonal malaria transmission assessed through different methods
Download presentation
Tuberculosis
Aderemi Kehinde, University College Hospital, University of Ibadan, Nigeria
Pulmonary tuberculosis among health care workers in Ibadan, Nigeria
Download presentation
Jossy van den Boogaard, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands
Widespread Fluoroquinolone sale in northern Tanzania: A potential threat for Fluoroquinolone use in tuberculosis treatment
Download presentation
Werner Maokola, Ifakara Health Institute, Dar es Salaam, Tanzania
Improving diagnosis of pulmonary tuberculosis in resource-limited settings
Download presentation
Nathaniel Brittain, University of Oxford, United Kingdom
A phase II, randomized study to evaluate the protective efficacy against TB disease of Mva85a in HIV-infected adults in South Africa, Senegal, and The Gambia
Download presentation
Hadija Semvua, Kilimanjaro Christian Medical Centre (KCMC), Moshi, Tanzania
Low rate of antituberculosis drug-induced hepatotoxicity in Tanzanian hospitalized pulmonary tuberculosis patients
Download presentation
Gaspary Mwanyika, NIMR-Mbeya Medical Research Programme, Tanzania
Assessment of DNA stability in urine from healthy adults in Mbeya,Tanzania
Download presentation
Anne Wajja, Makerere University Infectious Diseases Institute, Kampala, Uganda
Sharing experiences and optimising south-to-south collaboration in preparing resource-limited sites for vaccine trials: the TB vaccine sites
Download presentation
Kayla Laserson, U.S. Centers for Disease Control and Prevention, USA
CDC’s tuberculosis trials consortium
Download presentation
Peter Nyasulu, School of Public Health, University of the Witwatersrand, Johannesburg, South Africa
Complementary role of Mycobacterium w immunotherapy for treating tuberculosis: A systematic review
Download presentation
Yared Merid, Armauer Hansen Research Institute, Addis Ababa, Ethiopia
Validation of bleach treated smears for the diagnosis of pulmonary tuberculosis
Download presentation
Cross-cutting issues
Peter Olupot-Olupot, Mbale Hospital, Uganda
Capacity building on HIV/AIDS care in the eastern regions of Uganda, a collaborative initiative of the UK and Ugandan physicians: A model for capacity building
Download presentation
Roma Chilengi, KEMRI/Wellcome Trust, Kilifi, Kenya
Creating web-based platforms for teaching research ethics and GCP to Africa
Download presentation
Bornwell Sikateyo, Ministry of Health, Directorate of Public Health and Research, Lusaka, Zambia
Understanding the consent undertaken by research participants in an enterotoxigenic vaccines trial (in HIV sero pisitive people) in Misisi, Lusaka
Download presentation
Aceme Nyika, African Malaria Network Trust (AMANET), Dar es Salaam, Tanzania
Data management and archiving systems of a cohort of African Ethics Review Committees: From paper-based to electronic systems
Download presentation
Jonathan Kayondo, Uganda Virus Research Instutite (UVRI), Entebbe, Uganda
Uganda Virus Research Institute (UVRI), EDCTP, IANPHI and MRC (UK): A successful example of capacity development through an international partnership
Download presentation
Samba Cor Sarr, Ministry of Health & Medical Prevention, Dakar, Senegal
Governance of health research in Africa: The Senegalese example
Download presentation
Dominique Sprumont, University of Neuchatel, Switzerland
Training and resources in research ethics evaluation for Africa (TRREE for Africa)
Download presentation
Adeyinka Falusi, University of Ibadan, Nigeria
Capacity development in health research ethics – A unique and practical experience in a developing country
Download presentation
Fonju Fausta, Cineca Inter-University Consortium, Bologna, Italy
An IT platform to support Clinical Research in East Africa
Download presentation
Phetogo Phoi, Supply Chain Management System (SCMS), Gaborone, Botswana
A new tool for quantifying laboratory commodities: The Botswana experience
Download presentation
Josephine Birungi, The AIDS Support Organisation (TASO), Kampala, Uganda
Networking for research capacity development- TASO Uganda
Download presentation
Julius Ecuru, Uganda National Council for Science and Technology, Kampala, Uganda
Alternative strategies for ensuring quality research ethics: The case of Uganda
Download presentation
Steve Wandiga, KEMRI/CDC, Kisumu, Kenya
Professional Development Program (PDP)for clinical research staff in Kisumu, Kenya using a network of partners in preparation for future TB vaccine trials
Download presentation
Emma Hancox, Medical Research Council, Banjul, The Gambia
The importance of introducing quality practices in clinical research
Download presentation
Niresh Bhagwandin, South African Medical Research Council, Cape Town, South Africa
Towards a Clinical Research Organization (CRO) – Major considerations and challenges
Download presentation
Peter Wasswa, Makerere University, Mayuge Demographic Surveillance Site, Igange, Uganda
Strategies for developing staff capacity to conduct GCP compliant clinical research in limited resource settings
Download presentation
Joyce Kemilembe Ikingura, Tanzania Commission for Science & Technology, Dar es Salaam, Tanzania
Capacities and capabilities of Research Ethics Review Committees (RECs) in Africa
Download presentation
James Watiti, East, Central and Southern African Health Community, Tanzania
Regional information and advocacy support model for health research utilization
Download presentation
Derrick Elemu, University of Zambia, Lusaka, Zambia
Are ethical clinical trials possible without formal ethics instruction in medical schools?
Download presentation
Isidore Tiandiogo Traore, Centre Muraz, Ouagadougou, Burkina Faso
Establishment of a HIV vaccine cohort among clandestine female sex workers in Ouagadougou, Burkina Faso: Situation analysis of sexual and reproductive health and HIV need
Download presentation
Filed Under: Cross-cutting issues, HIV/AIDS, Malaria, Monday, Presentations, Tuberculosis, Tuesday, Wednesday
